As of 2025-05-04, the Relative Valuation of NeuroMetrix Inc (NURO) is (125.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.58 USD, the upside of NeuroMetrix Inc based on Relative Valuation is -2840.7%.
The range of the Relative Valuation is (125.43) - (134.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 26.3x - 39.9x | 32.8x |
| Forward P/E multiples | 33.1x - 35.4x | 33.5x |
| Fair Price | (125.43) - (134.22) | (125.52) |
| Upside | -2838.6% - -3030.5% | -2840.7% |
| Date | P/E |
| 2025-05-01 | -1.21 |
| 2025-04-30 | -1.15 |
| 2025-04-29 | -1.15 |
| 2025-04-28 | -1.15 |
| 2025-04-25 | -1.15 |
| 2025-04-23 | -1.15 |
| 2025-04-22 | -1.15 |
| 2025-04-21 | -1.14 |
| 2025-04-17 | -1.17 |
| 2025-04-16 | -1.15 |
| 2025-04-15 | -1.16 |
| 2025-04-14 | -1.15 |
| 2025-04-10 | -1.16 |
| 2025-04-09 | -1.14 |
| 2025-04-08 | -1.16 |
| 2025-04-07 | -1.16 |
| 2025-04-04 | -1.16 |
| 2025-04-03 | -1.17 |
| 2025-04-02 | -1.17 |
| 2025-04-01 | -1.16 |
| 2025-03-31 | -1.17 |
| 2025-03-28 | -1.17 |
| 2025-03-27 | -1.19 |
| 2025-03-26 | -1.17 |
| 2025-03-25 | -1.17 |
| 2025-03-24 | -1.21 |
| 2025-03-21 | -1.19 |
| 2025-03-20 | -1.21 |
| 2025-03-19 | -1.16 |
| 2025-03-18 | -1.16 |
| 2025-03-17 | -1.16 |
| 2025-03-14 | -1.15 |
| 2025-03-13 | -1.15 |
| 2025-03-12 | -1.15 |
| 2025-03-11 | -1.15 |
| 2025-03-10 | -1.15 |
| 2025-03-07 | -1.16 |
| 2025-03-06 | -1.16 |
| 2025-03-05 | -1.15 |
| 2025-03-04 | -1.15 |
| 2025-03-03 | -1.15 |
| 2025-02-28 | -1.15 |
| 2025-02-27 | -1.16 |
| 2025-02-26 | -1.16 |
| 2025-02-25 | -1.16 |
| 2025-02-24 | -1.16 |
| 2025-02-21 | -1.16 |
| 2025-02-20 | -1.17 |
| 2025-02-19 | -1.16 |
| 2025-02-18 | -1.15 |